Ischemic and non-ischemic acute kidney injury cause hepatic damage  by Golab, Fereshteh et al.
Ischemic and non-ischemic acute kidney injury cause
hepatic damage
Fereshteh Golab1, Mehri Kadkhodaee1, Maryam Zahmatkesh1, Mehdi Hedayati2, Hossein Arab3,
Rebecca Schuster4, Kamyar Zahedi5, Alex B. Lentsch4 and Manoocher Soleimani5
1Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; 2Endocrine and Metabolism
Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 3Department of Pharmacology, School of Veterinary
Medicine, Tehran University, Tehran, Iran; 4Department of Surgery, University of Cincinnati, Cincinnati, OH, USA and 5Department of
Medicine, University of Cincinnati, Cincinnati, OH, USA
Recent studies have documented that remote organs are
affected by ischemic injury to the kidney. Here we studied
whether the liver also suffers damage during induction of
renal ischemia–reperfusion in rats and compared this to
bilateral nephrectomy. Hepatic levels of tumor necrosis
factor-a increased significantly after 6 and 24 h of renal
ischemia or nephrectomy. Malondialdehyde, an index of lipid
peroxidation, increased while total glutathione was
decreased in the liver in both the renal ischemia and
nephrectomy groups, suggesting activation of oxidative
stress. Expression of liver spermine-spermidine acetyl
transferase, an enzyme upregulated in early phases of
hepatic injury was significantly increased 6 h after either
kidney ischemia or nephrectomy. Apoptosis was increased in
hepatocytes 24 h after nephrectomy. We also found
histological evidence of hepatocyte injury following both
ischemia and bilateral nephrectomy. Infusion of reduced
glutathione, before the induction of renal ischemia,
significantly improved liver architecture and was associated
with a reduction in hepatic malondialdehyde and serum
alanine transaminase levels. Our study shows that acute
kidney ischemia or renal failure activates oxidative stress and
promotes inflammation, apoptosis, and tissue damage in
hepatocytes.
Kidney International (2009) 75, 783–792; doi:10.1038/ki.2008.683;
published online 28 January 2009
KEYWORDS: acute kidney injury; bilateral nephrectomy; ischemia-
reperfusion; liver; oxidative stress; remote organ
Acute kidney injury (AKI), as manifested by a decline in renal
function, is a serious complication in hospitalized patients
and is associated with a profound mortality rate among those
who require dialytic treatment.1–3 Among the predictors of
mortality in these patients are the comorbid conditions,
causes of acute kidney failure, the severity of kidney injury
and its complications. Epidemiological studies have identi-
fied a close relationship between kidney injury and other
organ system failures. Furthermore, although the mortality in
patients with kidney injury has improved over the past
decade, these findings are restricted to only those patients
without other organ-system dysfunction.1 Given the poor
clinical outcome in these patients, there is a need to study the
mechanisms of systemic and remote organ effects in AKI,
which in turn may lead to discovery of disease-modifying
targets.1
The remote organ dysfunction in AKI is thought to be due
to humoral and/or cellular mediators circulating in the
blood.2 Cytokines that are released during ischemia–reperfu-
sion (IR) may play an important role in the pathogenesis of
tissue injury. Tumor necrosis factor (TNF-a), which is
produced by tubular epithelial cells, as well as by activated
leukocytes, induces the expression of adhesion molecules in
endothelial cells, possibly enhancing leukocyte infiltration in
IR. TNF-a induces other proinflammatory or anti-inflam-
matory cytokines, such as interleukin 6 (IL-6), IL-8, and
IL-10, which may in turn affect other organ systems.3 A
recent study indicated that the administration of IL-6
inactivating antibody decreased the markers of pulmonary
damage following AKI.4
Several mechanisms such as production of reactive oxygen
species (ROS) and oxidative damage are thought to directly
contribute to the activation of inflammatory pathways and
worsening of organ function in a variety of diseases.5,6 Thus,
ROS can be considered as signaling molecules, which trigger
several pivotal mechanisms of reperfusion injury.7
However, the exact mechanisms of remote organ dysfunc-
tion in the setting of ischemic AKI remain unclear. This is
specifically confounded by the fact that ischemic AKI can
potentially affect remote organ function.1,8 In a rat model of
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renal IR or bilateral nephrectomy, Rabb et al.9 found a
downregulation in pulmonary epithelial Naþ channels, Na-
K-ATPase, and aquaporin 5. The extent of lung injury,
characterized by pulmonary vascular congestion and neu-
trophil infiltration, was similar after ischemic AKI and
bilateral nephrectomy.10
The intensive care unit setting is replete with studies
that show that AKI along with markers of liver cell damage
profoundly elevate mortality risk.11 Further, liver plays a
critical role in metabolic function in critical illness including
drug metabolism. As such, liver injury along with renal
injury further complicates effective treatments in intensive
care unit.
In this study, we investigated the impact of ischemic and
non-ischemic AKI on liver function and structure. Toward
this end, animals were subjected to either acute IR injury
(IRI) or bilateral nephrectomy and examined 6 or 24 h later.
In follow-up studies, the efficacy of a potential intervention,
the antioxidant glutathione (GSH) administration, on
amelioration of liver injury in AKI was examined.
Our studies show that AKI increases the expression of
proinflammatory cytokine and damage-inducing molecules,
promotes apoptosis and causes cell damage in the liver.
However, the administration of GSH significantly attenuates
the liver damage in kidney IRI. The importance of the results
will be discussed.
RESULTS
Hemodynamic parameters
The mean arterial pressure during the experimental periods
was not significantly different from their basal values
(109±10.9 and 110±7.8 mm Hg, respectively) in IR, bilat-
eral nephrectomy, and sham groups.
Biochemical assays
Renal IRI led to a significant rise in serum creatinine
and blood urea nitrogen (BUN) relative to sham animals
(Figure 1a and b). As shown, bilateral nephrectomy resulted
in a much higher elevation in serum creatinine and BUN
levels.
Liver function tests were evaluated in all groups. As shown
in Table 1, aspartate aminotransferase, alanine aminotrans-
ferase, and lactate dehydrogenase levels in the blood were
increased in rats that were subjected to either nephrectomy or
45 min ischemia and examined 6 h later. These parameters
were returned toward baseline after 24 h.
Levels of cytokines after ischemic renal injury and bilateral
nephrectomy
The concentration of cytokines was measured in liver tissues
at 6 or 24 h after renal reperfusion or bilateral nephrectomy.
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Figure 1 | Serum creatinine and BUN in various experimental
groups with renal injury. Serum creatinine (mg/100 ml; a) and
blood urea nitrogen (BUN; mg/100 ml; b) were determined in all
groups. Renal IRI led to a significant rise in serum creatinine and
BUN relative to sham-operated animals, and bilateral
nephrectomy led to a much higher elevation in serum creatinine
and BUN levels. Bilat. neph, bilateral nephrectomy; IRI,
ischemia–reperfusion injury. Results are the mean±s.e.m.
*Po0.05 compared with sham. #Po0.05 compared with IRI 24 h.
$Po0.05 compared with IRI 6 and 24 h and Bilat. neph 6 h (n¼ 7).
Table 1 | Liver function tests in experimental groups
Groups AST (U/l) ALT (U/l) LDH (U/l) ALK (U/l)
Sham 203.2±38.4 117.2±23.1 357.2±115.9 471.2±70.6
45 min ischemia +6 h reperfusion 392.8±78.2* 479.3±65.3* 1123±188.4* 415.7±57.1
Sham 174.5±36.3 87.5±31.3 209.3±53.3 352±55.7
Bilateral nephrectomy 6 h 390.8±75.5* 374±40.4* 1033±185.3* 451.5±50.3
Sham 143.5±12 45.7±5.8 325.4±37 334±29.8
45 min ischemia +24 h reperfusion 225.5±17 66.2±6.3 520.8±85.7 367.6±28.2
Sham 141.4±10 61.1±7.7 370.1±87.8 395.8±36.7
Bilateral nephrectomy 24 h 145.4±15 54.1±7.8 392.1±68.7 346.7±22.4
ALK, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDH, lactate dehydrogenase.
Liver function tests were measured in all groups. AST, ALT, and LDH were increased in rats subjected to 45 min ischemia/6 h reperfusion or 6 h bilateral nephrectomy and
returned toward baseline after 24 h. Results are the mean±s.e.m.
*Po0.05 compared with other groups (n=7).
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As shown in Figure 2, the concentration of TNF-a increased
significantly at 6 and 24 h after renal IRI or bilateral
nephrectomy compared with sham-operated animals. The
highest increase in TNF-a levels was observed at 24 h after
bilateral nephrectomy (Figure 2).
The increase in proinflammatory cytokines is usually
associated with an increase in anti-inflammatory cytokines,
such as IL-10, which is a pluripotent cytokine produced by
many activated immune cell types, including macrophages,
monocytes, and keratinocytes.12 Figure 3 shows that the
concentration of the anti-inflammatory cytokine IL-10 was
greatly elevated in the liver at 6 and 24 h after reperfusion of
the ischemic kidneys or bilateral nephrectomy compared
with sham-operated animals. The highest increase in IL-10
levels was observed at 24 h after bilateral nephrectomy
(Figure 3).
Effect of ischemic renal injury and bilateral nephrectomy on
lipid peroxidation
Figure 4 shows the levels of malondialdehyde (MDA), an
index of lipid peroxidation, in liver tissue homogenates
obtained from the experimental groups. As indicated, MDA
levels increased significantly at 6 h after reperfusion of the
ischemic kidneys or bilateral nephrectomy compared with
sham-operated animals. MDA levels also increased signifi-
cantly 24 h after bilateral nephrectomy.
Effect of ischemic acute renal injury and bilateral nephrect-
omy on total glutathione (GSH levels)
Figure 5 shows the levels of GSH in liver homogenates of the
experimental groups. As indicated, both IRI and bilateral
nephrectomy caused a significant depletion of GSH levels
relative to sham-operated groups.
Expression of injury-promoting molecules in the liver
The above studies show that AKI secondary to ischemic
injury or bilateral nephrectomy activates oxidative stress and
increases the levels of proinflammatory cytokines in the liver.
These results are consistent with the presence of injury in the
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Figure 2 | Liver tumor necrosis factor (TNF)-a concentrations
in various experimental groups with renal injury. The
concentration of TNF-a increased significantly at 6 and 24 h after
renal IRI or bilateral nephrectomy compared with sham-operated
animals. The highest increase in TNF-a levels was observed at 24 h
after bilateral nephrectomy. Bilat. neph, bilateral nephrectomy; IRI,
ischemia–reperfusion injury. Results are the mean±s.e.m.
*Po0.05 compared with sham. #Po0.05 compared with IRI 6 and
24 h and Bilat. neph 6 h (n¼ 7).
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Figure 3 | Liver interleukin (IL)-10 in various experimental
groups with renal injury. The concentration of IL-10 increased
significantly at 6 and 24 h after renal IRI or bilateral nephrectomy
compared with sham-operated animals. The highest increase in
IL-10 levels was observed at 24 h after bilateral nephrectomy. Bilat.
neph, bilateral nephrectomy; IRI, ischemia–reperfusion injury.
Results are the mean±s.e.m. *Po0.05 compared with sham.
#Po0.05 compared with IRI 6 and 24 h and bilat. neph 6 h (n¼ 7).
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Figure 5 | Liver GSH in various experimental groups with renal
injury. As indicated, both IRI and bilateral nephrectomy caused a
significant depletion of GSH levels relative to sham-operated
groups. Bilat. neph, bilateral nephrectomy; IRI, ischemia–
reperfusion injury. Results are the mean±s.e.m. *Po0.05
compared with sham (n¼ 7).
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Figure 4 | Liver malondialdehyde (MDA) in various
experimental groups with renal injury. MDA levels increased
significantly at 6 h after reperfusion of the ischemic kidneys or
bilateral nephrectomy compared with sham-operated animals.
MDA levels also increased significantly 24 h after bilateral
nephrectomy. Bilat. neph, bilateral nephrectomy; IRI,
ischemia–reperfusion injury. Results are the mean±s.e.m.
*Po0.05 compared with sham (n¼ 7).
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liver. Recent studies indicated that the expression of SSAT
(spermine/spermidine-N1-acetyl transferase), the key enzyme
in polyamine catabolic pathway, is upregulated in early
phases of hepatic or kidney reperfusion injury and leads to
increased production of reactive oxygen intermediates, which
contribute to oxidative tissue damage.13–15 We examined the
expression of SSAT in liver tissue after kidney IRI or bilateral
nephrectomy. As shown in Figure 6, the hepatic expression of
SSAT increased abundantly at 6 h after reperfusion or
bilateral nephrectomy but returned to baseline levels at 24 h
in both groups. When adjusted for RNA loading based on the
expression intensity of 28S rRNA, the levels of SSAT
expression increased by 3.4±0.4- and 2.8±0.35-fold at 6 h
in kidney IRI and bilateral nephrectomy, respectively
(Po0.05, n¼ 4 for each group). In addition to SSAT, the
expression of the injury-inducing molecule CARF (colla-
borator with ARF-alternate reading frame), which activates
p53 and causes cell injury16,17 was also increased at 6 h after
reperfusion or bilateral nephrectomy (data not shown).
Published reports indicate that mRNA levels of SSAT nicely
correlate with its enzymatic activity.
Immunohistochemical staining of activated caspase-3
In the next series of experiments, the presence of apoptosis in
hepatocytes was assayed by staining for cleaved caspase 3 by
using cleaved caspase-3 (Asp 175) antibody, as described in
Materials and Methods. As shown in Figure 7, the number of
hepatocytes displaying positive staining for activated caspase
3 was not significantly different at 6 h after nephrectomy or
reperfusion injury relative to sham-operated groups (top
panels). However, at 24 h after bilateral nephrectomy animals
showed significant increase in the number of hepatocytes
displaying activated caspase 3 staining relative to sham
(Figure 7, bottom panels). Activated caspase 3 staining at 24 h
after reperfusion injury was only mildly above baseline
relative to sham (Figure 7, bottom panels).
Liver histology after renal IRI or bilateral nephrectomy
Liver histology was assessed by hematoxylin and eosin
staining of liver sections. As shown in Figure 8a and b,
livers from sham-operated rats had normal liver histology.
At 6 h after reperfusion or bilateral nephrectomy, nuclear
and cytoplasmic degenerative changes, cellular vacuolization,
leukocyte infiltration and congestion were observed
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Figure 6 | Hepatic expression of spermidine/spermine
N-acetyltransferase (SSAT) in rats subjected to kidney IRI or
bilateral nephrectomy. Northern blot analyses were performed
(30mg/well total RNA) to examine the hepatic expression of SSAT
in the kidney after IRI or bilateral nephrectomy. The expression of
SSAT increased B3.5- and B2.5-fold at 6 h of reperfusion and
bilateral nephrectomy, respectively (n¼ 4; Po0.05 for each group
vs sham-operated animals). Equal loading was confirmed by
examination of the 18S rRNA bands (bottom).
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Figure 7 | Immunohistochemical staining of activated caspase-3 in hepatocytes. The number of hepatocytes displaying positive
staining for activated caspase 3 was not significantly different at 6 h after nephrectomy or reperfusion injury (middle panels, top and bottom
columns) relative to sham operated groups (left panels, top and bottom columns). At 24 h after bilateral nephrectomy animals showed
significant increase in the number of hepatocytes displaying activated caspase 3 staining relative to sham (right panel, bottom row vs left
panel, bottom row). Activated caspase 3 staining at 24 h after reperfusion injury was only mildly above baseline relative to sham (right
panel, top row vs left panel, top row).
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(Figure 8c and d). At 24 h after reperfusion, the severity of
injury was milder relative to 6 h, although areas of congestion
could be detected (Figure 8e). The severity of tissue injury
was more evident at 24 h after bilateral nephrectomy, as
manifested by the extent of cellular degenerative changes,
disintegrated cytoplasm, pyknotic and atypical nuclei, and
dilated microsomes (Figure 8f). Some degree of centrilobular
necrosis was observed in this group. Vascular congestion and
leukocyte (mainly lymphocyte) infiltration were also detected
after bilateral nephrectomy (Figure 8f).
Effect of GSH on liver injury after 45 min ischemia and 6 h of
reperfusion
To examine the role of oxidative stress in the pathophysiology
of liver injury in kidney IRI, rats were treated with reduced
form of GSH, which is an important protective antioxidant
molecule against free radicals and other oxidants.18 Figure 9a
and b shows that GSH pretreatment significantly reduced
liver MDA and blood ALT levels in rats subjected to 45 min
ischemia and 6 h reperfusion. Damage to liver architecture in
the GSH-treated rats was significantly improved as shown by
a reduction in vascular congestion, cytoplasmic vacuoliza-
tion, and leukocyte infiltration (Figure 9e) relative to 45 min
ischemia and 6 h reperfusion group that received no GSH
(Figure 9d). Sham-operated rats had normal liver histology
(Figure 9c).
Effect of 60 min renal ischemia/24 h reperfusion on liver
function and structure: comparison with 24 h bilateral
nephrectomy
In the next series of experiments, the impact of a more severe
renal injury resulting from a prolonged ischemia on liver
function and structure was examined. Toward this end,
animals were subjected to 60 min of ischemia and 24 h of
reperfusion and compared with animals subjected to 24 h of
bilateral nephrectomy. As shown in Figure 10a and b, 60 min
renal ischemia followed by 24 h reperfusion led to a
significant rise in serum creatinine and BUN that was
comparable with the levels observed in 24 h bilateral
nephrectomy group. Liver concentration of TNF-a was
increased in 60 min renal ischemia/24 h reperfusion group
but did not reach the same magnitude as in 24 h bilateral
nephrectomy group (Figure 10c). The microscopic analysis of
the structure of liver indicated that damage was less profound
in 60 min ischemic/24 h reperfusion (Figure 10e) relative to
24 h bilateral nephrectomy (Figure 10f). Sham-operated rats
had normal liver histology (Figure 10d).
DISCUSSION
The escalating mortality rate in patients with AKI necessitates
the design of strategies to better understand and assess the
impact of kidney injury on distant organs.19 Recent studies
have shown that isolated AKI has a much better prognosis
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Figure 8 | Liver histology at 6 and 24 h after sham operation (a and b), ischemia–reperfusion injury (c and d) and bilateral
nephrectomy (e and f). Sham-operated rat had normal liver histology. At 6 h after reperfusion or bilateral nephrectomy, nuclear and
cytoplasmic degenerative changes, cellular vacuolization, leukocyte infiltration and congestion were observed. At 24 h after reperfusion, the
severity of injury was milder relative to 6 h. The severity of tissue injury was more evident at 24 h after bilateral nephrectomy, as manifested
by the extent of cellular degenerative changes (black arrow), disintegrated cytoplasm, pyknotic and atypical nuclei, and dilated microsomes
(black arrow head) and congestion (white arrow). Magnifications:  400 in a–f.
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than AKI associated with multiple organ failure,1 and the
outcome of AKI is dependent on the severity of comorbid
conditions.20,21 It is shown that AKI secondary to ischemic or
non-ischemic causes can result in remote organ injury and
dysfunction. Cardiac and pulmonary injury have been
documented in both ischemic and non-ischemic AKI, and
changes in hepatic TNF-a levels and antioxidant status in
kidney IRI have been reported.9,22–24
It is worth mentioning that the role of inflammation has
been documented in cardiac or pulmonary dysfunction that
is observed in acute renal injury and/or failure. Cardiac
changes after experimental renal ischemia include cytokine
induction, leukocyte infiltration, cell death by apoptosis, and
impaired function.22 Similarly, pulmonary injury and
dysfunction after AKI has been shown to be mediated by
increased cytokine levels.4,10
The most salient feature of the present studies is the
demonstration of hepatic injury after AKI secondary to
ischemic or non-ischemic causes. The onset of liver injury
appeared in early stages of kidney injury and was associated
with increased levels of proinflammatory cytokine TNF-a,
activated oxidative stress, and decreased antioxidant levels,
and manifested by apoptosis, at least in renal failure that was
resulted from bilateral nephrectomy.
Acute kidney injury is considered a constant state of low-
grade, systemic inflammation with altered cytokine home-
ostasis.25 It has also been shown that the inflammation after
ischemia contributes to the maintenance and worsening of
AKI.26 Production of ROS and oxidative damage are thought
to directly contribute to the activation of inflammatory
pathways and worsening of renal function in a variety of
diseases.5,6 The increased expression of leukocyte-derived
NAD(P)H oxidase, as a major source of ROS, has been
detected in several tissues and is associated with a reduction
in the expression of antioxidants27 in uremic patients,
suggesting an imbalance between oxidant and antioxidant
mechanisms.28,29
The antioxidant function of GSH is well established in
physiological and pathophysiological states.30,31 Several
laboratories have documented the presence of glutathione
depletion in kidneys in ischemic AKI.32–34 GSH is a tripeptide
(L-g-glutamyl-L-cysteinyl-glycine) containing a thiol (sulfhy-
dryl) group. GSH acts as an important protective antioxidant
by scavenging free radicals and other oxidants. A reduction in
tissue GSH levels may contribute to an imbalance between
oxidants and antioxidants status and may amplify injury and
potentiate tissue damage,18 consistent with protective effect
of GSH against ROS.35 Treatment of cold preserved livers
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Figure 9 | Effect of GSH treatment on liver function and structure in kidney IRI. GSH treatment significantly decreased blood alanine
aminotransferase (ALT) (a) and hepatic malondialdehyde (MDA) (b) levels and protected against structural damage to liver (c–e) in rats
subjected to IRI. Sham-operated (c), IRI (d) and GSH-treated animals (e) are shown for comparison. Sham-operated rats had normal liver
histology. At 6 h after reperfusion, nuclear and cytoplasmic degenerative changes, cellular vacuolization, leukocyte infiltration, and
congestion were observed. IRI: ischemia–reperfusion injury. Results are the mean±s.e.m. *Po0.05 compared with sham (n¼ 7).
Magnification:  400 in c–e.
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with 2 or 4 mmol GSH upon reperfusion prevented cell
damage to hepatocytes in a model of cell-free rat liver
perfusion.36 In this study, we found that intravenous
administration of GSH significantly protects the rat liver
against kidney reperfusion injury, as shown by improvement
in histology and prevention of the increase in plasma ALT
levels and liver lipid peroxidation.
The expression of the injury-promoting molecule SSAT
increased significantly as early as 6 h after reperfusion or
bilateral nephrectomy (Figure 6). Recent studies showed that
SSAT is induced in the early stages of reperfusion in kidney
and liver and plays an important role in the pathophysiology
of injury and dysfunction in both tissues. The activation of
SSAT was associated with enhanced polyamine catabolism
and generation of putrescine and reactive oxygen intermedi-
ates, toxic molecules that can cause tissue damage.13–15 The
SSAT-deficient animals are significantly protected against
kidney and liver reperfusion injury and failure (Zahedi K,
Lentsch AB, Okaya T, Barone S, Witte DP, Ja¨nne J, Alhone L,
Porter CW, Soleimani M, unpublished data). The protection
against kidney or hepatic injury and failure was associated
with the prevention of generation of putrescine and reactive
oxygen intermediates, supporting the important role of
polyamine catabolic pathway in tissue injury (unpublished
data). The hepatic injury persisted while the expression of
SSAT returned to baseline levels at 24 h after surgery
(Figure 6). This is very similar to hepatic or kidney
reperfusion injury and indicates that SSAT functions as an
initial switch, which activates other injurious cascades.
Alternatively, SSAT-independent pathways may become
activated at 24 h after surgery.
The examination of hepatocytes indicated a significant
increase in the number of cells with activated caspase 3
staining at 24 h after bilateral nephrectomy (Figure 7).
The increase in the number of apoptotic cells correlated
with the severity of renal injury (Figure 1), levels of the
proinflammatory cytokine TNF-a, and the extent of cell
damage in liver (Figure 8). The signal initiating the apoptotic
response in bilateral nephrectomy remains speculative.
The current studies parallel recent studies indicating
* *
0
1
2
3
4
Sham IRI 60 Bilat. neph
Cr
 (m
g/1
00
 m
l)
*
*
0
30
60
90
120
150
Sham IRI 60 Bilat. neph
BU
N 
(m
g/1
00
 m
l)
*
*,#
0
200
400
600
Sham IRI 60 Bilat. neph
TN
F-
α
(pg
/10
0 m
g t
iss
ue
)
Figure 10 | Effect of 60 min renal ischemia/24 h reperfusion on liver function and structure. Comparison with 24 h bilateral
nephrectomy. Subjecting the rats to 60 min renal ischemia followed by 24 h reperfusion led to a significant rise in serum creatinine
(a) and blood urea nitrogen (BUN) (b) that was comparable with the level observed in 24 h bilateral nephrectomy group. Liver concentration
of tumor necrosis factor (TNF)-a was increased in 60 min renal ischemia/24 h reperfusion group but did reach the same magnitude
as in 24 h bilateral nephrectomy (c). The microscopic analysis of the structure of liver indicated that damage was less profound in 60 min
ischemic/24 h reperfusion (e) relative to 24 h bilateral nephrectomy (f). Sham-operated rats had normal liver histology (d). Data used in
these graphs for bilateral nephrectomy are the same as in Figures 1 and 2. Bilat. neph, bilateral nephrectomy; IRI 60: 60 min ischemia and
24 h reperfusion injury. Results are the mean±s.e.m. *Po0.05 compared with sham. #Po0.05 compared with IRI 60 (n¼ 7). Magnification:
 400 in d–f.
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enhanced pulmonary damage in animals with bilateral
nephrectomy.10 It is plausible that uremic toxins along
with oxidative stress promote hepatic injury in AKI. The role
of oxidative stress in the pathophysiology of hepatic damage
in AKI is specifically highlighted by our studies, showing the
protective effect of GSH treatment on hepatic injury in AKI
(Figure 9).
The presence of liver damage in animals following IRI or
bilateral nephrectomy is significant and indicates that
kidney injury per se and independent of its etiology
can promote liver injury. Coupled with the studies indicating
that AKI impairs pulmonary capillary permeability and
cardiac function,9,22,23 these results suggest that AKI
can initiate or exacerbate a state of multi-system organ
dysfunction. It is plausible that the increased mortality rate in
hospitalized patients with AKI is in part secondary to remote
multi-organ dysfunction or failure secondary to kidney
failure.
In conclusion, acute ischemic or non-ischemic renal
injury activates oxidative stress, decreases antioxidant levels,
and upregulates the expression of injury-promoting mole-
cules in liver. The severity of liver damage and cell death
correlates with the severity of kidney injury. We suggest that
patients with acute severe renal injury should be monitored
for evidence of liver damage. If, indeed, the severity of renal
injury predisposes to hepatic and/or pulmonary injury, early
dialytic treatment aimed at removing uremic toxins and well
before overt uremia may improve the outcome and survival
in patients with AKI.
MATERIALS AND METHODS
Animals
Male Wistar rats (250–300 g) were housed in standard conditions
(12-h light/day cycle with 20–22 1C temperature and 40–50%
humidity) and had free access to commercial chow and water. All
procedures described here had prior approval from the University
Animal Ethics Committee.
Surgical protocol
The renal IRI or bilateral nephrectomy was performed as
described.37,38 The following surgical procedures were performed
on these animals: (1) renal IRI, (2) renal IRI—sham operation,
(3) bilateral nephrectomy, and (4) bilateral nephrectomy—sham
operation. Rats were anaesthetized by intraperitoneal injection
of pentobarbital sodium (60 mg/kg; Sigma-Aldrich, Steinheim,
Germany), and placed on a thermoregulated table. After tracheot-
omy, the tail vein was cannulated (using Venflon 22GA, 0.98IN,
ID 0.8 mm, Helsingborg, Sweden) and 0.9% normal saline
was infused to maintain euvolemia. The right femoral artery
was cannulated (Vasculon 25GA, 0.75IN, ID 0.6 mm) and connected
to a pressure transducer (MLT 0380, ADInstruments, Castle Hill,
Australia) for mean arterial pressure and heart rate monitoring,
which were recorded using a PowerLab/4sp data acquisition system
(Software Chart, version 5.0.1, ADInstruments).
A midline incision was made, and the renal pedicles were
identified. In the ischemic groups, an atraumatic vascular clamp
(Biemerclip, Aesculap, Germany) was placed around both renal
arteries for 45 min, followed by 6 or 24 h of reperfusion. Throughout
the experiment, the abdomen was temporarily closed to avoid
excessive loss of fluids. After clamp removal, kidneys were observed
for restoration of blood flow by the return to their original color.
Sham-operated animals underwent identical surgical procedure,
including isolation of both renal arteries. However, the occlusion of
the arteries was not performed.
In the bilateral nephrectomy model, both renal pedicles were tied
off with suture, then cut distal to the suture, and the kidneys were
removed. Sham-operated animals underwent identical surgical
procedure, including isolation of both renal pedicles but kidneys
were not removed.
Collection and preparation of samples
Rats were euthanized 6 and 24 h after surgery. Blood samples were
collected and centrifuged at 4000 g for 10 min at 4 1C, and the serum
was collected for chemical analysis. Kidney and one half of hepatic
tissues were fixed in formalin (10% phosphate-buffered, pH¼ 7.4)
for histological evaluations. Remainders of hepatic tissues were
partly washed in cold phosphate-buffered saline to measure renal
GSH levels and partly snap-frozen in liquid nitrogen. The samples
were stored at 70 1C until further study.
Biochemical assay
Blood concentrations of creatinine, BUN, and liver function tests
were determined by colorimetric methods using commercially
available kits.
Measurement of liver oxidative stress markers
Total glutathione (GSH) concentration was measured according to
the method of Tietze that was modified by Griffith.39,40 The tissue
MDA level was determined by method of Esterbauer and Cheese-
man41 based on its reaction with thiobarbituric acid at 90–100 1C
and measurement of the absorbance at 532 nm.
Determination of serum and liver cytokine concentrations
Cytokine concentrations including TNF-a and IL-10 were measured
in both serum and liver using enzyme-linked immunosorbent assay
(ELISA) method (Rat IL-10, TNF-a; ELISA kit, Diaclone A tepnel
Company, Besankon, France).
For preparation of liver samples, 100 mg of liver tissue were
homogenized in 1 ml of phosphate-buffered saline containing
antiproteases (0.1 mmol/l phenylmethylsulfonyl fluoride,
0.1 mmol/l benzethonium chloride, 10 mmol/l EDTA, and 20
kallikrein inhibitor unit (KI) aprotinin A and 0.05% Tween 20).
The samples were then centrifuged for 10 min at 3000 r.p.m. and the
supernatant was used for ELISA assays.
RNA isolation and northern hybridization
Total cellular RNA was extracted from livers (30 mg/lane), size
fractionated on a 1.2% agarose-formaldehyde gel and transferred to
nylon membranes by capillary transfer using 10 SSPE buffer.
Membranes were crosslinked by UV light or baked. Hybridization
was performed according to Church and Gilbert.42 Membranes
were washed, blotted dry, exposed to PhosphorImager screens at
room temperature for 24–72 h, and scanned by PhosphorImager.
A 32P-labeled cDNA fragment of the mRNA-encoding rat SSAT
(corresponding to nucleotides 323–892, accession number
NM_009121) or mouse CARF (corresponding to nucleotides
721–1583, accession number NM_172407) was used as a specific
probe.
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Activated (cleaved) caspase-3 immunohistochemical staining
Apoptosis was assessed by immunohistochemical staining
using specific antibodies, which detect the activation of caspase-3
in cells. The Cleaved Caspase-3 (Asp175) IHC Detection kit (catalog
no. 8120, Cell Signalling Technology, Danvers MA), which uses
cleaved caspase-3 (Asp 175) antibody bound by a biotinylated
secondary antibody was used for the immunohistochemical
staining.
Histological analysis
After formalin fixation (10% phosphate-buffered pH¼ 7.4) and
dehydration process, paraffin-embedded hepatic sections (4mm)
were stained by hematoxylin and eosin. Histopathology for all
tissues was evaluated per section in at least 10 randomly selected
non-overlapping fields at 400 magnifications of the sections. The
liver sections were examined for the presence of congestion, cellular
degenerative changes, cytoplasmic vacuolization, leukocyte infiltra-
tion, and cellular necrosis.
GSH administration
Rats received 5 mmol/kg body weight of reduced form of GSH
(Sigma, St Louis, MO) dissolved in 1 ml of sterile saline (PH¼ 7.4)
or vehicle (saline) through tail-vein injection after anesthesia and
before ischemia.
Statistical analysis
Results are expressed as means±s.e.m. The statistical significance
was determined by using one-way analysis of variance followed by
Duncan post hoc test. Results with a Po0.05 were considered
significant. For the quantitation of the expression levels of SSAT in
northern hybridization experiments, the intensity of each transcript
on the membrane was measured by PhosphorImager and normal-
ized by dividing onto the intensity of labeling of its corresponding
28S rRNA.
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